SCHEMBL10349986

SCHEMBL10349986

CC1(C(=O)O)CC(C(=O)O)(c2ccc([N+](=O)[O-])cc2)C1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 2/20 0.46
MAPT P10636 1/20 0.46
HTR1E P28566 1/20 0.46
S1PR3 Q99500 1/20 0.46
MEN1 O00255 2/20 0.45
CYP1A2 P05177 2/20 0.45
CYP2C19 P33261 2/20 0.45
KMT2A Q03164 2/20 0.45
CYP2C9 P11712 1/20 0.45
TDP1 Q9NUW8 1/20 0.44
MAPK1 P28482 2/20 0.43
LMNA P02545 2/20 0.42
TSHR P16473 2/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2D6 P10635 1/20 0.42
ALOX15 P16050 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
CES1 P23141 2/20 0.42
HTT P42858 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10549794 1.00 NPSR1 (0.46) NPSR1MAPTHTR1ES1PR3MEN1
SCHEMBL1769201 0.83 NPSR1 (0.50) NPSR1MAPTHTR1ES1PR3MEN1
SCHEMBL3900070 0.80 AKR1C1 (0.59) NPSR1MAPTHTR1ES1PR3MEN1
SCHEMBL3224174 0.80 NPSR1 (0.55) NPSR1MAPTHTR1ES1PR3MEN1
SCHEMBL10548355 0.76 CES1 (0.44) NPSR1MAPTHTR1ES1PR3MEN1
SCHEMBL3904809 0.76 L3MBTL1 (0.64) NPSR1MAPTHTR1ES1PR3MEN1
SCHEMBL10350123 0.76 CES1 (0.44) NPSR1MAPTHTR1ES1PR3MEN1
SCHEMBL3909752 0.75 ALDH1A1 (0.55) NPSR1MAPTHTR1ES1PR3MEN1
SCHEMBL6607473 0.75 NPSR1 (0.52) NPSR1MAPTHTR1ES1PR3MEN1
SCHEMBL31488838 0.73 NPC1 (0.50) NPSR1MAPTMEN1KMT2ATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4857660-A ENZYME INHIBITORS, ANTICANCER AGENTS CIBA-GEIGY CORPORATION (US) 1989-08-15 US claimed
EP-0166692-B1 SUBSTITUTED AZABICYCLOHEPTANES, THEIR USE, PHARMACEUTICAL COMPOSITIONS COMPRISING THEM AND PROCESS FOR THE PREPARATION OF THE COMPOUNDS CIBA-GEIGY AG (CH) 1990-07-11 EP disclosed
US-4857660-A ENZYME INHIBITORS, ANTICANCER AGENTS CIBA-GEIGY CORPORATION (US) 1989-08-15 US disclosed
US-4764640-A AROMATOSE INHIBITOR CIBA-GEIGY CORPORATION (US) 1988-08-16 US disclosed
US-4677129-A Substituted-3-azabicyclo[3.1.1]heptane-2,4-diones useful for treating hormone-dependent diseases CIBA-GEIGY CORPORATION (US) 1987-06-30 US disclosed
EP-0166692-A2 Substituted azabicycloheptanes, their use, pharmaceutical compositions comprising them and process for the preparation of the compounds CIBA-GEIGY AG (CH) 1986-01-02 EP disclosed